Form 8-K - Current report:
SEC Accession No. 0000950170-25-047220
Filing Date
2025-03-31
Accepted
2025-03-31 08:00:08
Documents
15
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K jagx-20250331.htm   iXBRL 8-K 43760
2 EX-99.1 jagx-ex99_1.htm EX-99.1 64407
3 GRAPHIC img107817981_0.jpg GRAPHIC 14479
4 GRAPHIC img107817981_1.jpg GRAPHIC 86211
5 GRAPHIC img107817981_2.jpg GRAPHIC 214946
  Complete submission text file 0000950170-25-047220.txt   666476

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT jagx-20250331.xsd EX-101.SCH 24902
17 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20250331_htm.xml XML 4708
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 25788972
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)